# Two Supplemented Against Skin Reactivity

> **NCT01368224** · PHASE3 · COMPLETED · sponsor: **L'Oreal** · enrollment: 96 (actual)

## Conditions studied

- Skin Sensitivity
- Trans-epidermal Water Loss
- Clinical Score
- Assessment of Skin Moisturization Factors
- Assessment of Serum Immune-regulatory Cytokine
- Evaluation of Intestinal Flora Composition

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus paracasei NCC 2461 and Bifidobacterium longum NCC3001

## Key facts

- **NCT ID:** NCT01368224
- **Lead sponsor:** L'Oreal
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2011-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01368224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01368224, "Two Supplemented Against Skin Reactivity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01368224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*